Analyst Ratings for Cartesian Therapeutics (RNAC)
RNAC Rating Summary
RNAC Price Target Summary
- Highest: $44.00 (BTIG)
- Lowest: $16.00 (Cantor Fitzgerald)
- Average: $31.25
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$31.25 (+278.3%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 88%
Avg. $ Target:
$31.25 (+278.3%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 88%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/9/2026 | Cantor Fitzgerald | Kristen Kluska | Upgrade | Overweight (Neutral) |
16.00 (N/A) |
6.85 (8.26) |
20.58% | Details |
| 7/9/2025 | Wedbush | Martin Fan | New Coverage | Outperform (N/A) |
38.00 (N/A) |
11.30 (8.26) |
-26.9% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
